|
Volumn 58, Issue 4, 2008, Pages 445-452
|
Influenza;Grippe
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMANTADINE;
AMOXICILLIN;
AMOXICILLIN PLUS CLAVULANIC ACID;
CEFOTAXIME;
CEFOTIAM HEXETIL;
CEFPODOXIME PROXETIL;
CEFTRIAXONE;
CEFUROXIME AXETIL;
INFLUENZA VACCINE;
LEVOFLOXACIN;
MOXIFLOXACIN;
OSELTAMIVIR;
ZANAMIVIR;
ANTIBIOTIC THERAPY;
CHLAMYDIA;
DIAGNOSTIC PROCEDURE;
DIFFERENTIAL DIAGNOSIS;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FRANCE;
HUMAN;
INFLUENZA;
INFLUENZA VACCINATION;
INFLUENZA VIRUS;
MYCOPLASMA;
RESPIRATORY SYNCYTIAL PNEUMOVIRUS;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
REVIEW;
SARS CORONAVIRUS;
SEROLOGY;
THORAX RADIOGRAPHY;
ADOLESCENT;
ADULT;
AGE FACTORS;
AGED;
AMANTADINE;
ANTI-BACTERIAL AGENTS;
ANTIVIRAL AGENTS;
CHILD;
CHILD, PRESCHOOL;
DIAGNOSIS, DIFFERENTIAL;
FEMALE;
FOLLOW-UP STUDIES;
FRANCE;
HUMANS;
INFANT;
INFLUENZA VACCINES;
INFLUENZA, HUMAN;
MALE;
OSELTAMIVIR;
PREGNANCY;
PREGNANCY COMPLICATIONS, INFECTIOUS;
RISK FACTORS;
SEASONS;
TIME FACTORS;
TREATMENT OUTCOME;
ZANAMIVIR;
|
EID: 40649087882
PISSN: 00352640
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (1)
|
References (0)
|